Role of Duloxetine in attenuating catheter related bladder discomfort

Phase 4

• Conditions: Health Condition 1: null- elective surgery for carcinoma pancrease, carcinoma common bile duct, carcinoma breast, gallbladder stone under general anesthesia, who will be catheterized after induction

• Registration Number: CTRI/2014/07/004781
• Lead Sponsor: il

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Adult patients (18 â?? 60 yr) with an ASA I and II

2.Of either sex,

3.All patients undergoing elective surgery under general anesthesia, who will be catheterized after induction,

Exclusion Criteria

1.Patients with a history of bladder out�ow obstruction,

2.transurethral resection of prostate for benign prostate hyperplasia,

3.elderly patients (age .60 yr),

4.overactive bladder (frequency: more than three times in the night or more than eight times in 24 h)

5.End-stage renal disease (urine output ,500 ml per 24 h),

6.morbid obesity,

7.disturbance of central nervous system,

8.chemical substance abuse,

9.chronic pain,

10.Chronic analgesic usage.

11.cardiovascular, and hepatic or any psychiatric disease

12.Pregnancy and lactating mothers

Study & Design

• Study Type: Interventional
• Study Design: Not specified